163 related articles for article (PubMed ID: 38471622)
21. Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS).
Li J; Wang Z; Liu W; Tan L; Yu Y; Liu D; Wei Z; Zhang S
Cancer Biomark; 2023; 37(2):67-84. PubMed ID: 37248885
[TBL] [Abstract][Full Text] [Related]
22. Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3.
Netzel BC; Cradic KW; Bro ET; Girtman AB; Cyr RC; Singh RJ; Grebe SK
Clin Chem; 2011 Mar; 57(3):431-40. PubMed ID: 21245371
[TBL] [Abstract][Full Text] [Related]
23. Across-polarity quantification method for broad metabolome coverage based on consecutive nanoconfined liquid phase nanoextraction technology: Application in discovering the plasma potential biomarkers of different types of cancer.
Yu C; Zhang Q; Zou Y; Liu R; Zhao J; Bi K; Li D; Li Q
Anal Chim Acta; 2021 Jul; 1167():338577. PubMed ID: 34049631
[TBL] [Abstract][Full Text] [Related]
24. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
25. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Medicine (Baltimore); 2019 Jun; 98(26):e16192. PubMed ID: 31261558
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma.
Kim SI; Hwangbo S; Dan K; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Han D; Lee M
Mol Cell Proteomics; 2023 Mar; 22(3):100502. PubMed ID: 36669591
[TBL] [Abstract][Full Text] [Related]
28. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
[TBL] [Abstract][Full Text] [Related]
30. Plasma metabolomic profiling in workers with noise-induced hearing loss: a pilot study.
Miao L; Wang B; Zhang J; Yin L; Pu Y
Environ Sci Pollut Res Int; 2021 Dec; 28(48):68539-68550. PubMed ID: 34275074
[TBL] [Abstract][Full Text] [Related]
31. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
32. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
33. Altered neopterin and IDO in kynurenine metabolism based on LC-MS/MS metabolomics study: Novel therapeutic checkpoints for type 2 diabetes mellitus.
Liu Z; Ma Z; Jin L; Nizhamuding X; Zeng J; Zhang T; Zhang J; Wang J; Zhao H; Zhou W; Zhang C
Clin Chim Acta; 2024 Apr; 557():117859. PubMed ID: 38518968
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
35. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
36. LC-MS/MS based metabolomic analysis of serum from patients with cerebrovascular stenosis.
Shan D; Xu D; Hu S; Qi P; Lu J; Wang D
J Pharm Biomed Anal; 2023 Oct; 235():115608. PubMed ID: 37527609
[TBL] [Abstract][Full Text] [Related]
37. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
38. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
39. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
Huang D; Gaul DA; Nan H; Kim J; Fernández FM
J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
[TBL] [Abstract][Full Text] [Related]
40. Use of ultra high performance liquid chromatography with high resolution mass spectrometry to analyze urinary metabolome alterations following acute kidney injury in post-cardiac surgery patients.
Bai Y; Zhang H; Wu Z; Huang S; Luo Z; Wu K; Hu L; Chen C
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():31-40. PubMed ID: 35252948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
